Rocket


News + Filings
Transactions





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other



Torley Helen Create: Alert

All | News | Filings
Date FiledTypeDescription
08/17/2023 4 Torley Helen (PRESIDENT AND CEO) has filed a Form 4 on HALOZYME THERAPEUTICS, INC.
Txns: Sold 10,000 shares @ $43.768, valued at $437.7k
Sold 10,000 shares @ $43.532, valued at $435.3k
Sold 10,000 shares @ $43.182, valued at $431.8k
Exercised 10,000 options to buy @ $13.87, valued at $138.7k
Exercised 10,000 options to buy @ $13.87, valued at $138.7k
Exercised 10,000 options to buy @ $13.87, valued at $138.7k
07/27/2023 4 Torley Helen (PRESIDENT AND CEO) has filed a Form 4 on HALOZYME THERAPEUTICS, INC.
Txns: Sold 10,000 shares @ $42.796, valued at $428k
Sold 10,000 shares @ $42.689, valued at $426.9k
Sold 10,000 shares @ $43.79, valued at $437.9k
Exercised 10,000 options to buy @ $13.87, valued at $138.7k
Exercised 10,000 options to buy @ $13.87, valued at $138.7k
Exercised 10,000 options to buy @ $13.87, valued at $138.7k
03/09/2023 4 Torley Helen (PRESIDENT AND CEO) has filed a Form 4 on HALOZYME THERAPEUTICS, INC.
Txns: Sold 10,000 shares @ $45.469, valued at $454.7k
Sold 10,000 shares @ $43.259, valued at $432.6k
Sold 10,000 shares @ $42.727, valued at $427.3k
Exercised 10,000 options to buy @ $14.66, valued at $146.6k
Exercised 10,000 options to buy @ $14.66, valued at $146.6k
Exercised 10,000 options to buy @ $14.66, valued at $146.6k
03/01/2023 4 Torley Helen (PRESIDENT AND CEO) has filed a Form 4 on HALOZYME THERAPEUTICS, INC.
Txns: Gifted 10,000 shares @ $0
02/21/2023 4 Torley Helen (PRESIDENT AND CEO) has filed a Form 4 on HALOZYME THERAPEUTICS, INC.
Txns: Sold 11,061 shares @ $49.26, valued at $544.9k
Exercised 21,010 restricted stock units @ $0
Granted 193,360 options to buy @ $49.26, valued at $9.5M
Granted 67,499 restricted stock units @ $0
02/14/2023 4 Torley Helen (PRESIDENT AND CEO) has filed a Form 4 on HALOZYME THERAPEUTICS, INC.
Txns: Paid exercise price by delivering 16,469 shares @ $48.92, valued at $805.7k
Paid exercise price by delivering 17,266 shares @ $48.92, valued at $844.7k
Exercised 31,281 restricted stock units @ $0
Exercised 32,794 restricted stock units @ $0
02/09/2023 4 Torley Helen (PRESIDENT AND CEO) has filed a Form 4 on HALOZYME THERAPEUTICS, INC.
Txns: Sold 10,000 shares @ $51.258, valued at $512.6k
Sold 10,000 shares @ $51.357, valued at $513.6k
Sold 10,000 shares @ $50.4, valued at $504k
Exercised 10,000 options to buy @ $14.66, valued at $146.6k
Exercised 10,000 options to buy @ $14.66, valued at $146.6k
Exercised 10,000 options to buy @ $14.66, valued at $146.6k
01/19/2023 4 Torley Helen (PRESIDENT AND CEO) has filed a Form 4 on HALOZYME THERAPEUTICS, INC.
Txns: Sold 8,897 shares @ $50.395, valued at $448.4k
Sold 1,103 shares @ $50.929, valued at $56.2k
Sold 10,000 shares @ $51.047, valued at $510.5k
Sold 10,000 shares @ $52.414, valued at $524.1k
Exercised 10,000 options to buy @ $14.66, valued at $146.6k
Exercised 10,000 options to buy @ $14.66, valued at $146.6k
Exercised 10,000 options to buy @ $14.66, valued at $146.6k
12/15/2022 4 Torley Helen (PRESIDENT AND CEO) has filed a Form 4 on HALOZYME THERAPEUTICS, INC.
Txns: Sold 9,507 shares @ $58.639, valued at $557.5k
Sold 493 shares @ $59.12, valued at $29.1k
Sold 10,000 shares @ $58.298, valued at $583k
Sold 9,104 shares @ $57.288, valued at $521.5k
Sold 896 shares @ $58.197, valued at $52.1k
Exercised 10,000 options to buy @ $14.66, valued at $146.6k
Exercised 10,000 options to buy @ $14.66, valued at $146.6k
Exercised 10,000 options to buy @ $14.66, valued at $146.6k
11/17/2022 4 Torley Helen (PRESIDENT AND CEO) has filed a Form 4 on HALOZYME THERAPEUTICS, INC.
Txns: Sold 9,987 shares @ $54.114, valued at $540.4k
Sold 13 shares @ $54.605, valued at $709.9
Sold 10,000 shares @ $53.899, valued at $539k
Sold 10,000 shares @ $52.149, valued at $521.5k
Exercised 10,000 options to buy @ $14.66, valued at $146.6k
Exercised 10,000 options to buy @ $14.66, valued at $146.6k
Exercised 10,000 options to buy @ $14.66, valued at $146.6k
02/17/2022 4 Torley Helen (President and CEO) has filed a Form 4 on HALOZYME THERAPEUTICS, INC.
Txns: Paid exercise price by delivering 6,892 shares @ $34.43, valued at $237.3k
Exercised 13,092 restricted stock units @ $0
Granted 257,046 options to buy @ $34.36, valued at $8.8M
Granted 84,037 restricted stock units @ $0
02/14/2022 4 Torley Helen (President and CEO) has filed a Form 4 on HALOZYME THERAPEUTICS, INC.
Txns: Paid exercise price by delivering 16,598 shares @ $34.94, valued at $579.9k
Paid exercise price by delivering 17,266 shares @ $34.2, valued at $590.5k
Paid exercise price by delivering 15,125 shares @ $33.64, valued at $508.8k
Exercised 31,282 restricted stock units @ $0
Exercised 32,795 restricted stock units @ $0
Exercised 28,729 restricted stock units @ $0
11/08/2021 4 Torley Helen (President and CEO) has filed a Form 4 on HALOZYME THERAPEUTICS, INC.
Txns: Sold 37,775 shares @ $39.62, valued at $1.5M
Sold 12,225 shares @ $40.419, valued at $494.1k
Exercised 50,000 options to buy @ $14.66, valued at $733k
10/04/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
09/07/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
08/10/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/06/2021 4 Torley Helen (President and CEO) has filed a Form 4 on HALOZYME THERAPEUTICS, INC.
Txns: Sold 50,000 shares @ $45.973, valued at $2.3M
Exercised 50,000 options to buy @ $14.66, valued at $733k
06/07/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/25/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/11/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
04/05/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/01/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/22/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/17/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/16/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/12/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/01/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
11/30/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
11/25/2020 4 Torley Helen (President and CEO) has filed a Form 4 on HALOZYME THERAPEUTICS, INC.
Txns: Sold 22,326 shares @ $40.174, valued at $896.9k
Sold 27,674 shares @ $41.181, valued at $1.1M
Exercised 50,000 options to buy @ $14.66, valued at $733k
08/14/2020 4 Torley Helen (President and CEO) has filed a Form 4 on HALOZYME THERAPEUTICS, INC.
Txns: Gifted 10,000 shares @ $0
05/21/2020 4 Torley Helen (Director) has filed a Form 4 on QUEST DIAGNOSTICS INC
Txns: Granted 1,531 shares @ $0
02/24/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/18/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/13/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy